Last quarter (Q ), Clinigen's total revenue was £―, a decrease of ― from the same quarter last year. In Q, Clinigen's net income was £―. See Clinigen’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jun 21	Jun 20	Jun 19	Jun 18	Jun 17
Total Revenue	-	£ 523.60M	£ 466.70M	£ 456.90M	£ 381.20M	£ 302.30M
Cost of Revenue	-	£ 325.70M	£ 261.60M	£ 274.60M	£ 242.50M	£ 179.60M
Gross Profit	-	£ 197.90M	£ 205.10M	£ 182.30M	£ 138.70M	£ 122.70M
Operating Expense	-	£ 136.40M	£ 135.50M	£ 124.30M	£ 89.00M	£ 77.90M
Operating Income	-	-	£ 69.60M	£ 58.00M	£ 49.70M	£ 44.80M
Net Non Operating Interest Income Expense	-	£ -9.70M	£ -19.60M	£ -11.90M	£ -6.40M	£ -31.50M
Other Income Expense	-	-	-	-	-	-
Pretax Income	-	£ 51.80M	£ 23.20M	£ 12.30M	£ 35.90M	£ 14.10M
Tax Provision	-	£ 12.10M	£ 9.00M	£ 7.10M	£ 8.50M	£ 10.30M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	-	-	£ 13.70M	£ 5.20M	£ 27.40M	£ 3.80M
Basic EPS	-	£ 22.80	£ 0.10	£ 0.04	£ 0.23	-
Diluted EPS	-	£ 22.30	£ 0.10	£ 0.04	£ 0.23	-
Basic Average Shares	-	£ 133.00	£ 132.70M	£ 129.80M	£ 119.90M	-
Diluted Average Shares	-	£ 135.00	£ 134.70M	£ 132.00M	£ 121.80M	-
Dividend Per Share	-	-	£ 0.07	£ 0.06	£ 0.05	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	£ 0.65	£ 0.54	£ 0.45	-
Reported Normalized Diluted E P S	-	-	£ 0.64	£ 0.54	£ 0.45	-
Rent Expense Supplemental	-	-	£ 0.00	£ 3.70M	£ 2.00M	£ 2.20M
Total Expenses	-	-	£ 397.10M	£ 398.90M	£ 331.50M	£ 257.50M
Net Income From Continuing And Discontinued Operation	-	£ 39.70M	£ 13.70M	£ 5.20M	£ 27.40M	£ 3.80M
Normalized Income	-	£ -932.40M	£ 35.93M	£ 32.08M	£ 33.88M	£ 3.80M
Interest Expense	-	-	£ 18.30M	£ 11.90M	£ 4.50M	£ 1.60M
EBIT	-	£ 61.50M	£ 41.50M	£ 24.20M	£ 40.40M	£ 15.70M
EBITDA	-	-	£ 96.20M	£ 65.95M	£ 64.20M	£ 34.90M

Currency in GBP

Clinigen Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing